July 2023 - Page 2 of 6 - NetworkNewsWire

WednesdayJul 26, 2023 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Patented DehydraTECH(TM) Technology Set to be Used in Multi-Billion Dollar Markets; On Track to have 2023 as Best Year Yet

Lexaria’s patented DehydraTECH(TM) technology enhances the performance of several categories of fat-soluble active molecules and drugs across oral and/or topical product formats This unique approach to drug delivery has earned Lexaria a total of 35 patents, with many patents pending worldwide The company continues active discussions with multi-billion dollar companies for the potential use of DehydraTECH in their commercial pursuits Lexaria is also actively seeking commercial partners during 2023 and 2024 Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is out on an ambitious move to address conditions with high unmet needs. This focus has allowed them…

TuesdayJul 25, 2023 9:45 am

D-Wave Quantum Inc. (NYSE: QBTS) Accelerates Commercial Quantum Adoption As Business and Government Interest in Quantum Computing Grows

D-Wave is working with a portfolio of impressive commercial customers including Mastercard, Deloitte, ArcelorMittal, Siemens Healthineers, Unisys, NEC Corporation, Pattison Food Group Ltd., DENSO, Lockheed Martin, and many more Governments worldwide are calling for the implementation of quantum applications – with the United States pushing for development and deployment of quantum applications within the next 24 months D-Wave, the world’s first commercial quantum computing solutions supplier, is successfully filling the increasing quantum needs of customers along with the growing interest of the government for expanding quantum technology D-Wave Quantum (NYSE: QBTS), a leader in commercial quantum computing systems, software, and…

TuesdayJul 25, 2023 9:00 am

Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Reports Promising Results from Texmont Project Amid Forecast of Growing Demand

Report projects that demand for nickel from the battery industry is set to increase significantly Texmont testing delivers results that meet or exceed expectations The company has acquired 403 additional mining claims within the Texmont ultramafic trend With experts predicting that nickel metal will play a key role in the 2023 battery-grade market (https://nnw.fm/AgbM9), Canada Nickel Company (TSX.V: CNC) (OTCQX: CNIKF) appears to be ideally positioned in the growing space. The company just released initial results from preliminary metallurgical testing at its Texmont Nickel Sulphide Project, and the results meet or exceed historical results (https://nnw.fm/4jtNT). Nickel metal has a key role…

MondayJul 24, 2023 10:30 am

Freight Technologies Inc. (NASDAQ: FRGT) Collaboration With Trucker Tools Boosts Strength of Shipping Networks in United States

Freight Technologies (aka Fr8Tech) is a growing commercial freight transportation technology developer whose flagship Fr8App platform helps shippers and carriers easily match loads and destinations in the USMCA Trucker Tools is a trip planning, shipment visibility, predictive freight matching and automated booking solutions company that has developed its flagship Smart Capacity(R) platform Fr8Tech recently announced integration of Trucker Tools’ network, boosting the pool of truck drivers able to use Fr8App by more than 315,000 carriers The collaboration is expected to increase the offers on loads by 75 percent and grow the carrier network for loads originating from and destined to…

MondayJul 24, 2023 9:45 am

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Reports Additional Copper Values at Los Azules Project; Eyes Further Value for Company

McEwen just reported new copper assays at its Los Azules project in San Juan, Argentina, the 9th largest undeveloped copper deposit in the world These results lead the company closer to realizing the full extent and economic potential of the deposit The latest drilling program, which began in October 2022 and concluded on June 19, 2023, has attracted new investment capital at rates implying a significant boost in the company’s value McEwen’s management is confident a future mine would support annual production of 415 million pounds of copper during its first 13 years at Los Azules, while creating long-term and…

MondayJul 24, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Publishes Eighth Peer-Reviewed Article in International Journal of Molecular Science

The article covers the concentration of cannabidiol in hypertensive women and men using the company’s patented DehydraTECH(TM)-processed CBD The global cardiovascular drugs market is expected to grow from $146.51 billion in 2021, reaching $173.48 billion in 2026, growing at a CAGR of 3.1% The article supports Lexaria’s efforts as it pursues IND status from the FDA for DehydraTECH-CBD as a potential treatment for hypertension Company is planning to begin preparations for a clinical trial that could start as early as the fourth quarter Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently announced that its groundbreaking research…

FridayJul 21, 2023 9:45 am

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) Continues to Support Cashless Society Technology by Meeting Mobile Money Needs Through Diverse Portfolio of Products and Services

Digital money is replacing physical cash and further supporting the growth of a growing cashless society driven by the pandemic and other factors FEXD supports the United Nations’ Sustainable Development Goals of reducing cross-border transaction costs from 7 percent to 3 percent FEXD plans to offer a diverse portfolio of products and services to consumers and businesses in the United States, South Asia, East Asia, Africa, Europe, and Latin America Financial technology, more commonly referred to as fintech, fuels economic growth and reduces inequality, poverty, and informality in underdeveloped companies. For impoverished people and small businesses without access to financial…

FridayJul 21, 2023 9:00 am

National GBM Awareness Events Underscore Significance of Clinical Trial Progress for CNS Pharmaceuticals, Inc. (NASDAQ: CNSP)

National awareness of glioblastoma tumors (“GBM”) sustained by Congressional leaders aim to improve efforts to treat brain cancers and ultimately improve patient survival GBM is a widely occurring, aggressive and effectively incurable brain cancer that few patients survive beyond three years U.S.-based drug developer CNS Pharmaceuticals is in the midst of a global potentially pivotal clinical trial for its lead pharmaceutical candidate, Berubicin, which it aims to show improves on standard of care chemotherapy agent Lomustine’s approach to treating GBM Berubicin is a novel anthracycline that is practically unique in its ability to cross the blood-brain barrier to directly target…

ThursdayJul 20, 2023 9:45 am

Explore the Future of the Internet at BREATHE! Convention with Key Insights on Emerging Tech Adoption

BREATHE! Convention at The Expo @ World Market Center Las Vegas will showcase the emerging and decentralized technology that continues to shape the future of work, art, finance, and more! Professionals interested in exploring the potential of Web3, Blockchain, AI, and other emerging tech applications are invited to attend the three-day event at one of the world’s largest and most recognized convention centers. “Anyone who attends, whether you are an emerging tech pro or newbie, has the opportunity to put the power of emerging tech applications into the palm of your hands,” says BREATHE! Public Relations Director Brian Edmiston. “BREATHE!…

ThursdayJul 20, 2023 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Is Building a Robust and Growing International Patent Portfolio for DehydraTECH(TM) in Support of Commercial Opportunities

Lexaria is a global innovator in drug delivery platforms with an expanding portfolio of patents that currently stands at 34 granted patents and many patents pending worldwide These patents pertain to the company’s method of improving bioavailability and taste as well as the use of DehydraTECH(TM) as a delivery platform for a wide variety of active pharmaceutical ingredients (“APIs”) The company has, since June 2015, simultaneously filed the US utility patent application and an international patent application under the Patent Cooperation Treaty (“PCT”) procedure, both through the USPTO The PCT procedure has made the process of initiating international patent applications…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: July 2023